Annals of Diagnostic Pathology
Volume 16, Issue 1 , Pages 7-12 , January 2012

Changing trends in human papillomavirus–associated head and neck squamous cell carcinoma

References 

  1. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15(22):6758–6762
  2. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–698
  3. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350
  4. Gallo A, Degener AM, Pagliuca G, et al. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg. 2009;141:276–281
  5. Ang KK, Harris J, Wheeler R. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35
  6. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–269
  7. Weinberger PM, Merkley MA, Khichi SS, et al. Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope. 2010;120(8):1531–1537
  8. Iftner T, Villa LL. Chapter 12: human papillomavirus technologies. J Natl Cancer Inst Monogr. 2003;31:80–88
  9. Schiffman M, Castle PE, Jeronimo J. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907
  10. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009;125:362–366
  11. Allen CT, Lewis JS, El-Mofty SK, et al. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope. 2010;120:1756–1772
  12. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121
  13. Sankaranarayanan R, Masuyer E, Swaminathan R. Head and neck cancer, a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779–4786
  14. Walker B, Figgs LW, Zahm SH. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect. 1995;103(Suppl 8):275–281
  15. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcomes. Head and Neck Pathol. 2009;3:186–194
  16. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007;117:2115–2128
  17. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630–5636
  18. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956
  19. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16–positive and human papillomavirus type 16–negative head and neck cancers. J. Natl. Cancer Inst. 2008;100:407–420
  20. Syrijanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004;57:449–455
  21. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev. 2005;14:467–475
  22. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–2623
  23. Paz IB, Cook N, Odom-Maryon T, et al. Human papillomavirus in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 1997;79:595–604
  24. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: and emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007;110:1429–1435
  25. Settle K, Posner MR, Schumaker LM. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res. 2009;2(9):776–781
  26. Chernock RD, Zhang J, El-Mofty SK, et al. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg. 2011;137:163–169
  27. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27(11):1463–1470
  28. El-Mofty SK, Patil S. Human papillomavirus (HPV)–related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:339–345

☆ Disclosure: This study was supported by intradepartment fund only.

PII: S1092-9134(11)00106-7

doi: 10.1016/j.anndiagpath.2011.07.003

Annals of Diagnostic Pathology
Volume 16, Issue 1 , Pages 7-12 , January 2012

Article Tools

* Image Usage & Resolution